Management of Multiple Sclerosis
NEJM 337:1604-1611, Rudick,R.A.,et al, 1997
Therapeutic Considerations in Patients with Refractory Neurosarcoidosis
Arch Neurol 52:875-879, Agbogu,B.N.,et al, 1995
The Treatment of Neurosarcoidosis with Cyclosporine
Arch Neurol 49:1065-1072, Stern,B.J.,et al, 1992
Cyclosporine-Assoc Seizures in Bone Marrow Transplant Given Busulfan & Cyclophosphamide Prep
Transplantation 52:310-315, Ghany,A.M.,et al, 1991
Efficacy & Toxicity of Cyclosporine in Chronic Progressive Multiple Sclerosis:A Randomized Clinical Trial
M. S. Study Group, Ann Neurol 27:591-605, 5890., , 1990
Randomised Double Blind Controlled Trial of Cyclosporin in Multiple Sclerosis
JNNP 52:559-565, Rudge,P.,et al, 1989
Cyclosporine Vs. Azathioprine in the Long-Term Treatment of Multiple Sclerosi-Results of German Multicenter Study
Ann Neurol 23:56-63, Kappos,L.,et al, 1988
Immunotherapy of Multiple Sclerosis
Ann Neurol 23:211-223, Weiner,H.L.&Hafler,D.A., 1988
Infectious and Non-Infectious Neurologic Complications in Heart Transplant Recipients
Medicine 89:166-175, Mu�oz,P., et al, 2010
Spectrum of Neurologic Events Following Cardiac Transplantation
Stroke 20:1586-1589, Sila,C.A., 1989
Drug-Induced Seizures:A 10-Year Experience
Neurol 34:1582-1586, Messing,R.O.,et al, 1984